BioSpace News Archive

Genetic Technologies Limited, a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifying risk and improving the health of populations worldwide.

Tevogen Bio Holdings Inc. reports publication of its phase I clinical trial data of TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTLs) immunotherapy by the journal Blood Advances.

BioVie Inc. today announced data from two presentations at the Advanced Therapeutics in Movement and Related Disorders Congress® (ATMRD Congress) held June 21-25, 2024 in Washington, D.C.

ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral vector manufacturing capabilities with the opening of a new state-of-the-art facility in Hopewell, New Jersey.

March of Dimes, the leading organization fighting for the health of all moms and babies, announced the three winners of the 2024 Discovery Research Grants.

Halozyme Therapeutics, Inc. announced that Roche received European Commission marketing authorization of OCREVUS® SC co-formulated with ENHANZE®, Halozyme’s proprietary recombinant human hyaluronidase enzyme, rHuPH20, for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.

Kuros Biosciences, a leader in next generation bone healing technologies, announced the publication of a peer-reviewed manuscript that details the clinical data of its MAXA Level 1 prospective, multi-center, randomized, intra-patient controlled clinical study in Spine 1.

Engitix Ltd announces the appointment of two biotech industry leaders as Scientific Advisors: Adrian S. Ray, PhD, and Scott Turner, PhD.

Exsilio Therapeutics, a biotechnology company developing genomic medicines for a broad range of diseases, announced its emergence from stealth with $82 million in Series A financing.

Zomedica Corp. announced it has secured the CE mark for its proprietary point-of-care TRUFORMA Bulk Acoustic Wave diagnostic platform.